South Korean Study to Prevent Frailty and Aging-related Diseases Through Lifestyle Intervention
SUPERAGING
A Multicenter, Feasibility Randomized Controlled Study to Evaluate the Applicability and Safety of the Software 'SUPERAGING' for Cognitive Therapy and Musculoskeletal Analysis in Frail or Prefrail Patients
1 other identifier
interventional
40
1 country
3
Brief Summary
The goal of this feasibility randomized controlled trial is to investigate the applicability of software that aims to improve symptoms of frailty by implementing customized interventions such as physical exercise and cognitive training implemented through a mobile app for 16 weeks for patients diagnosed with frailty or prefrailty. The primary outcomes are adherence, retention rates, and recruitment rates. Participants will participate in customized interventions including physical exercise, cognitive training, nutritional guidance, and management of disease related to frailty for 16 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2025
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 25, 2025
CompletedStudy Start
First participant enrolled
February 26, 2025
CompletedFirst Posted
Study publicly available on registry
March 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2026
CompletedNovember 20, 2025
November 1, 2025
10 months
February 25, 2025
November 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
retention rate
retention rate ≥ 70%
From enrollment to the end of intervention at 16 weeks
Adherence to the protocol
Adherence to the protocol ≥ 70%
From enrollment to the end of intervention at 16 weeks
recruitment rate
recruitment rate ≥ 50%.
From enrollment to the end of intervention at 16 weeks
Secondary Outcomes (29)
Change from Baseline in Korean Frailty Index for Primary Care at 16 weeks
From baseline to the end of intervention at 16 weeks
Change from Baseline in Modified Fried frailty phenotype score at 16 weeks
From baseline to the end of intervention at 16 weeks
Change from Baseline in Lubben Social Network Scale at 16 weeks
From baseline to the end of intervention at 16 weeks
Change from Baseline in 14-item cognitive subscale of the Alzheimer's Disease Assessment Scale at 16 weeks
From baseline to the end of intervention at 16 weeks
Change from Baseline in Korean Mini-Mental State Examination-2 at 16 weeks
From enrollment to the end of intervention at 16 weeks
- +24 more secondary outcomes
Study Arms (2)
Intervention group
EXPERIMENTALParticipants will receive interventions including exercise, cognitive training, nutrition education, and management of diseases related to frailty via the app for one hour per day, five days a week for 16 weeks.
Control
NO INTERVENTIONParticipants in the control group will receive standard treatment related to frailty during the study period and be provided with guidelines on 'Lifestyle habits for treating frailty or prefrailty'.
Interventions
For 16 weeks, participants will receive exercise, cognitive training, nutrition education, and disease education through a smartphone app, and the content and intensity of the intervention will be adjusted every four weeks through an assessment of frailty symptoms through the app.
Eligibility Criteria
You may qualify if:
- years of age
- Residing in the community
- Total score of Modified Fried frailty phenotype score ≥ 1 point
- Korean Mini-Mental State Examination-2 z-score ≥ -1.5
- Can read and write
- Being able to use the a mobile app through education or having someone help a participant use the mobile app
- Having a reliable informant who could provide investigators with the requested information.
- written informed consent
You may not qualify if:
- Major psychiatric illness such as major depressive disorders
- Dementia
- Other neurodegenerative disease (e.g., Parkinson's disease)
- Malignancy within five years
- Cardiac stent or revascularization within one year
- Serious or unstable symptomatic cardiovascular disease
- Other serious or unstable medical disease such as acute or severe asthma, active gastric ulcer, severe liver disease, or severe renal disease
- Severe loss of vision, hearing, or communicative disability
- Significant laboratory abnormality that may result in cognitive impairment
- Any conditions preventing cooperation as judged by the study physician
- Unable to participate in exercise program safely
- Coincident participation in any other intervention trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Inha University Hospital
Incheon, 22332, South Korea
Ewha Womans University Seoul hospital
Seoul, South Korea
Ajou University Hospital
Suwon, South Korea
Related Publications (1)
Jung S, Kang HJ, Moon SY, Choi M, Jung J, Kim HR, Jung S, Jeong JH, Choi SH, Park YK. South Korean study to prevent the progression of frailty and aging-related diseases using a digital multidomain intervention (SUPERAGING): Protocol of a feasibility pilot study. Digit Health. 2026 Jan 6;12:20552076251410995. doi: 10.1177/20552076251410995. eCollection 2026 Jan-Dec.
PMID: 41509872DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Seong Hye Choi, MD, PhD
Inha University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 25, 2025
First Posted
March 24, 2025
Study Start
February 26, 2025
Primary Completion
December 20, 2025
Study Completion
January 15, 2026
Last Updated
November 20, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- The data will become in 2027 and become available for 5 years.
- Access Criteria
- The access criteria is an approval of steering committee.
Individual participant data will be shared with the Global Alzheimer's Association Interactive Network.